Final Approval Of $1.4M Settlement Granted In Drug Maker’s Stock-Drop Suit
PHILADELPHIA — A federal judge in Pennsylvania granted final approval of a $1.4 million settlement in a securities class action lawsuit against a specialty pharmaceutical company and three of its senior...To view the full article, register now.
Already a subscriber? Click here to view full article